Articles

A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia: final results of the GIMEMA LAL 0904 study

Hematology, Department of Cellular Biotechnologies and Hematology, Policlinico Umberto 1, “Sapienza” University of Rome, Italy
Hematology, Department of Cellular Biotechnologies and Hematology, Policlinico Umberto 1, “Sapienza” University of Rome, Italy
GIMEMA Data Center, Rome, Italy
GIMEMA Data Center, Rome, Italy
GIMEMA Data Center, Rome, Italy
Hematology, Department of Cellular Biotechnologies and Hematology, Policlinico Umberto 1, “Sapienza” University of Rome, Italy
Institute of Hematology, University of Perugia, Italy
Hematology Unit, Azienda Ospedaliera Bianchi Melacrino Morelli, Reggio Calabria, Italy
Division of Hematology and Stem Cell Transplantation Unit, Cardarelli Hospital, Naples, Italy
Hematology Unit and Department of Pharmacy Services, Sant’Eugenio Hospital, Rome, Italy
Hematology Division, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy
Hematology Unit, Department of Medical Sciences, University of Cagliari, Italy
Department of Oncology/Hematology, Niguarda Cancer Center, Niguarda Ca’ Granda Hospital, Milano, Italy
Oncohematology Unit A. Tortora Hospital, Pagani, Salerno, Italy
Division of Hematology and Bone Marrow Transplantation, University Hospital, Udine, Italy
Department of Biomedical Sciences, University of Sassari, Italy
GIMEMA Data Center, Rome, Italy
Hematology, Department of Cellular Biotechnologies and Hematology, Policlinico Umberto 1, “Sapienza” University of Rome, Italy
Hematology, Department of Cellular Biotechnologies and Hematology, Policlinico Umberto 1, “Sapienza” University of Rome, Italy
Vol. 101 No. 12 (2016): December, 2016 https://doi.org/10.3324/haematol.2016.144535